- Home
- WMPN vs TELO Comparison
WMPN vs TELO Comparison
Compare WMPN & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMPN
- TELO
- Stock Information
- Founded
- WMPN 1870
- TELO 2021
- Country
- WMPN United States
- TELO United States
- Employees
- WMPN N/A
- TELO N/A
- Industry
- WMPN Savings Institutions
- TELO
- Sector
- WMPN Finance
- TELO
- Exchange
- WMPN Nasdaq
- TELO NYSE
- Market Cap
- WMPN 112.6M
- TELO 124.1M
- IPO Year
- WMPN N/A
- TELO 2024
- Fundamental
- Price
- WMPN $13.02
- TELO $4.47
- Analyst Decision
- WMPN Buy
- TELO
- Analyst Count
- WMPN 1
- TELO 0
- Target Price
- WMPN $14.00
- TELO N/A
- AVG Volume (30 Days)
- WMPN 89.0K
- TELO 75.3K
- Earning Date
- WMPN 10-16-2024
- TELO 11-12-2024
- Dividend Yield
- WMPN 0.92%
- TELO N/A
- EPS Growth
- WMPN N/A
- TELO N/A
- EPS
- WMPN N/A
- TELO N/A
- Revenue
- WMPN $20,360,000.00
- TELO N/A
- Revenue This Year
- WMPN N/A
- TELO N/A
- Revenue Next Year
- WMPN N/A
- TELO N/A
- P/E Ratio
- WMPN N/A
- TELO N/A
- Revenue Growth
- WMPN N/A
- TELO N/A
- 52 Week Low
- WMPN $10.80
- TELO $3.11
- 52 Week High
- WMPN $13.45
- TELO $20.72
- Technical
- Relative Strength Index (RSI)
- WMPN 56.24
- TELO 50.96
- Support Level
- WMPN $12.83
- TELO $3.20
- Resistance Level
- WMPN $13.45
- TELO $4.73
- Average True Range (ATR)
- WMPN 0.28
- TELO 0.45
- MACD
- WMPN -0.02
- TELO 0.06
- Stochastic Oscillator
- WMPN 63.57
- TELO 72.69
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.